Einat Weidberg, Ben Inbar, Daniel Kariv, Gal Shnaiberg and Sapir Krikev represented Cartiheal, a life sciences company that developed a coral-damaged cartilage repair implant, in a raising capital transaction in which Cartiheal raised $15-20 million from Bioventus Surgical at a company value of $180 million, before money.
